Substituted oxadiazolidinediones as PAI-1 inhibitors

Details for Australian Patent Application No. 2004275846 (hide)

Owner Wyeth

Inventors Elokdah, Hassan Mahmoud; Malamas, Michael Sotirios

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004275846

PCT Pub. Number WO2005/030204

Priority 10/947,856 23.09.04 US; 60/505,793 25.09.03 US

Filing date 24 September 2004

Wipo publication date 7 April 2005

International Classifications

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030204 Priority application(s): WO2005/030204

10 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275848-Rifalazil formulations

2004275845-Methods for treating bladder dysfunction